We thank Weng et al. (1) for their interest in our article regarding the incidence of type 1 diabetes (T1D) in the Chinese population (2). Such epidemiologic data are important from clinical practice and policy perspectives, while comprehensive population-based estimates of T1D incidence rates and trends are still limited in China (3–5).
